1. Home
  2. LEGN vs XP Comparison

LEGN vs XP Comparison

Compare LEGN & XP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEGN
  • XP
  • Stock Information
  • Founded
  • LEGN 2014
  • XP 2001
  • Country
  • LEGN United States
  • XP Cayman Islands
  • Employees
  • LEGN N/A
  • XP N/A
  • Industry
  • LEGN Biotechnology: Pharmaceutical Preparations
  • XP Investment Bankers/Brokers/Service
  • Sector
  • LEGN Health Care
  • XP Finance
  • Exchange
  • LEGN Nasdaq
  • XP Nasdaq
  • Market Cap
  • LEGN 5.4B
  • XP 10.6B
  • IPO Year
  • LEGN 2020
  • XP 2019
  • Fundamental
  • Price
  • LEGN $37.84
  • XP $19.29
  • Analyst Decision
  • LEGN Strong Buy
  • XP Strong Buy
  • Analyst Count
  • LEGN 12
  • XP 5
  • Target Price
  • LEGN $73.82
  • XP $23.80
  • AVG Volume (30 Days)
  • LEGN 1.8M
  • XP 5.4M
  • Earning Date
  • LEGN 08-08-2025
  • XP 08-12-2025
  • Dividend Yield
  • LEGN N/A
  • XP 7.14%
  • EPS Growth
  • LEGN N/A
  • XP 15.23
  • EPS
  • LEGN N/A
  • XP 1.51
  • Revenue
  • LEGN $728,303,000.00
  • XP $2,886,046,386.00
  • Revenue This Year
  • LEGN $65.49
  • XP $18.86
  • Revenue Next Year
  • LEGN $53.76
  • XP $13.03
  • P/E Ratio
  • LEGN N/A
  • XP $12.88
  • Revenue Growth
  • LEGN 112.46
  • XP 9.27
  • 52 Week Low
  • LEGN $27.34
  • XP $10.82
  • 52 Week High
  • LEGN $60.87
  • XP $20.64
  • Technical
  • Relative Strength Index (RSI)
  • LEGN 65.70
  • XP 49.21
  • Support Level
  • LEGN $34.64
  • XP $19.48
  • Resistance Level
  • LEGN $36.91
  • XP $19.97
  • Average True Range (ATR)
  • LEGN 1.48
  • XP 0.37
  • MACD
  • LEGN 0.18
  • XP -0.13
  • Stochastic Oscillator
  • LEGN 90.94
  • XP 24.40

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

About XP XP Inc.

XP Inc is a Cayman Island-based technology-driven financial services platform. It is a provider of low-fee financial products and services in Brazil. The company evaluates its business through a single segment such as monitoring operations, making decisions on fund allocation, and evaluating the performance. It generates revenue through the Brokerage commission.

Share on Social Networks: